Metabolic control of T cell activation and death in SLE.
Metabolic control of T cell activation and death in SLE.
复制标题
SLE 中 T 细胞激活和死亡的代谢控制。
DOI:
10.1016/j.autrev.2008.07.041
复制
发表时间:
2009-01
影响因子:
13.6
通讯作者:
Perl, Andras
中科院分区:
文献类型:
--
作者:
Fernandez, David;Perl, Andras
Systemic lupus erythematosus (SLE) is characterized by abnormal T-cell activation and death, processes which are crucially dependent on the controlled production of reactive oxygen intermediates (ROI) and of ATP in mitochondria. The mitochondrial transmembrane potential (Δψm) has conclusively emerged as a critical checkpoint of ATP synthesis and cell death. Lupus T cells exhibit persistent elevation of Δψm or mitochondrial hyperpolarization (MHP) as well as depletion of ATP and glutathione which decrease activation-induced apoptosis and instead predispose T cells for necrosis, thus stimulating inflammation in SLE. NO-induced mitochondrial biogenesis in normal T cells accelerates the rapid phase and reduces the plateau of Ca2+ influx upon CD3/CD28 co-stimulation, thus mimicking the Ca2+ signaling profile of lupus T cells. Treatment of SLE patients with rapamycin improves disease activity, normalizes CD3/CD28-induced Ca2+ fluxing but fails to affect MHP, suggesting that altered Ca2+ fluxing is downstream or independent of mitochondrial dysfunction. Understanding the molecular basis and consequences of MHP is essential for controlling T-cell activation and death signaling in SLE. Lupus T cells exhibit mitochondrial dysfunction Mitochondrial hyperpolarization (MHP) and ATP depletion predispose lupus T cells to death by necrosis which is pro-inflammatory MHP is caused by depletion of glutathione and exposure to nitric oxide (NO) NO-induced mitochondrial biogenesis regenerates the Ca2+ signaling profile of lupus T cells Rapamycin treatment normalizes Ca2+ fluxing but not MHP, suggesting that the mammalian target of rapamycin, acts as a sensor and effector of MHP in SLE
登录
查看更多内容
影响因子:
4.8
作者:
Banki, K;Hutter, E;Perl, A
通讯作者:
Perl, A
影响因子:
15.3
作者:
Gilkeson, GS;Mudgett, JS;Seldin, MF;Ruiz, P;Alexander, AA;Misukonis, MA;Pisetsky, DS;Weinberg, JB
通讯作者:
Weinberg, JB
DOI:
10.1073/pnas.261560998
发表时间:
2001-12-18
影响因子:
11.1
作者:
Almeida, A;Almeida, J;Moncada, S
通讯作者:
Moncada, S
影响因子:
32.4
作者:
Ibiza, Sales;Victor, Victor M.;Serrador, Juan M.
通讯作者:
Serrador, Juan M.
DOI:
10.1006/clin.1996.0192
发表时间:
1996-12-01
期刊:
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY
影响因子:
--
作者:
Kovacs, B;Vassilopoulos, D;Tsokos, GC
通讯作者:
Tsokos, GC